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Abstract
Background: Infectious diseases are the most common causes of morbidity and mortality in developing countries.
Wound and wound infections are also major health problem. Nowadays, medicinal plants play a major role in
treatment of infectious diseases and wound healing and they are easily available and more affordable as compared
to synthetic compounds. The aim of this study is therefore, to investigate the antibacterial and wound healing
activities of 80% methanol extract of Hibiscus micranthus leaves using disc diffusion methods and rat excision
model respectively.
Methods: In vitro antibacterial screening was carried out against S. aureus, S.pneumoniae, S. pyogenes, E. coli, P.
aeruginosa, K. pneumoniae and P. mirabilis bacterial strains using disc-well diffusion assay. Would healing activity was
done in rats divided into four groups each consisting of six animals. Group I was served as a negative control
(ointment base), Group II served as a positive control Nitrofurazone (NFZ 0.2% ointment), Groups III and IV was
treated 5 and 10% extracts respectively. The acute oral toxicity test and skin sensitivity test were also performed
before conducting the actual study. The extract was analyzed for secondary metabolites using standard methods.
Results: Preliminary phytochemical screening have revealed the presence of alkaloids, flavonoids, saponins, tannins,
steroids, phenols, diterpines, anthraquinones and the absence of glycosides, terpinoides and triterpines. Based on
acute oral toxicity test the extract was found to be safe up to a dose of 2 g/kg. In addition, acute dermal toxicity
test indicated no sign of skin irritation. The leaves extract exhibited varying degrees of sensitivity with zones of
inhibition ranging from 14.00 ± 0.333 (S.pyogenes) to 22.67 ± 1.202 mm (S.aureus). It was found that S. aureus and S.
pneumonia (p < 0.05) were the most sensitive to the extracts of the leaves at concentrations of 800 μg/ml and
400 μg/ml respectively followed by P. aeuruginosa [(18.33 ± .333 mm) (p < 0.05)] at a concentration of 400 μg/ml.
However, E. coli and P. mirabilis were found to be resistant to the extract at any of the applied doses. In the wound
healing study, the 5 and 10% w/w extract exhibited significant wound contraction rate of 99.30% and 99.13% as
compared to NFZ ointment and simple ointment base treated groups from 6th to 16th day, respectively (p < 0.05).
Conclusion: The present study suggests that the methanol extract of the leaves exhibited a potential antibacterial
activity against the tested microorganisms and wound healing activity.
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Background
Infectious diseases are the most common causes of
morbidity and mortality in developing countries [1].
Deaths from infectious diseases occur disproportionately
in the developing world, where they are the biggest killer
of children and young adults [2]. Globally, use of antibi-
otics has contributed to the dramatic fall in morbidity
and mortality from communicable and infectious dis-
eases over the last 50 years. However, the control of in-
fectious diseases is seriously threatened by the steady
increase in the number of microorganisms that are re-
sistant to antimicrobial agents [1]. John et al., (2011) de-
scribed that the widespread use of broad spectrum
antibiotics has led to the emergence of several resistant
strains of microbes. These contribute significantly
towards rise in the escalating health care costs and pa-
tients’ morbidity and mortality [3]. In general, bacterial
infections are one of the main problems in the world
and should be treated by antimicrobial agents. The in-
creased prevalence of known resistant organisms and
the emergence of newly resistant organisms have
resulted in delayed effective therapy, increase length of
hospitalization and have led to increased cost for
patients [2].
Wound and wound infections also represent a major
health problem both in terms of morbidity and mortality
which are most common in developing countries be-
cause of poor hygienic conditions [4, 5]. Pattayanac,
Sunita (2011) and European Wound Management Asso-
ciation (2005) described that S. aureus, S. pyogenes, E.
coli, P. aeroginosa, S. pneumoniae and K. pneumoniae
are some important organisms causing wound infections
[4, 5]. Wound infection and associated delayed healing
present significant challenges for clinicians predomin-
antly with respect to identifying infection and choosing
appropriate treatment options [5].
On the other hand, the world is rich with natural
products including medicinal plants. Medicinal plants
are now getting more attention than ever because they
have potential of numerous benefits as a source of drugs
to all mankind. The medicinal value of these plants lies
on bioactive phytochemical constituents that produce
definite physiological action on the human body. Some
of the most important bioactive phytochemical constitu-
ents are alkaloids, essential oils, flavonoids, tannins,
terpenoids, saponins, phenolic compounds and many
more. These natural compounds are the foundations of
modern drugs as we know today [6].
Hibiscus micranthus Linn: Hibiscus is a genus in the
family of malvaceae encompasses more than 300 species
[7]. Hibiscus micranthus (malvaceae) is a shrub up to
3 m, stem erect, branched, usually with stiff, slender and
stellately hairy plant (Fig. 1). There is a constant need
for effective and cost-effective therapies to treat bacterial
infections and promote wound healing and then plant
products offer an alternative that needs to be developed.
One alternative will be H.micranthus. The research
which was done by Naji and Luca (2013), the highest
anthocyanin content was obtained from methanol ex-
tract of H. micranthus than ethanol extract which may
be responsible for antioxidant effects [8]. According to
the secondary metabolites present in the plant, the plant
has been used for its antipyretic, anti-inflammatory,
hematological effects, antifungal, antiviral, antitumor, fe-
male antifertility, viralizing, as hypoglycemic agent and
anabolizing activities [9]. Some compounds like phenolic
acids, tannins, flavonoids, β-sitosterol, alkanes, carbohy-
drates, steroids, fatty alcohols and acids have been re-
ported [10, 11]. The roots are also used traditionally
chewed as a cure for cough in India [12], used to cure
venereal diseases in Sudan, applied as dressings on
wounds and sores of humans and domestic animals and
are also taken to cure bronchitis and pneumonia in
Kenya and Tanzania [13]. In Tanzania, the leaves are
used for treating earache, the leaves sap is taken against
dysentery, water in which leaves have been pounded is
taken against stomach-ache and leaf pulp is applied on
swellings, used as an antidote for snakebites and as a
treatment for kidney problems. In Tanzania and Zambia,
the whole plant is used to treat convulsive fever in
children [13].
In Ethiopia, the leaves of this plant provides medicines
traditionally for treating skin burning (dermatological in-
fections) and skeleto muscular disorders [8], swellings
Fig. 1 Images of Hibiscus micranthus Linn. (a) Plant (b) Coarse dried powder
Begashaw et al. BMC Complementary and Alternative Medicine  (2017) 17:337 Page 2 of 11
over body [14, 15], for wound healing or sore in Tigray
region [16]. The leaf and the flower of the plant is also
used for wound and dermatological purposes by chewed
and creamed with cotton in Amhara region, in and
around Tara Gedam, South Gonder Zone [17]. Hibiscus
micranthus also uses for burn in Negelle-Borona,
Ethiopia [18].
Sohel A. et al., demonstrated that the flower extracts
of Hibiscus rosa-sinensis had stronger antibacterial ef-
fects [19]. Shivanada et al., has also found that an etha-
nol extract of Hibiscus rosa sinensis has properties that
provide it capable of promoting accelerated wound heal-
ing activity in animal model [20]. From literature search,
no scientific investigations have been conducted till date
to verify the use of H. micranthus as antimicrobial and
wound healing remedies even though the Hibiscus rosa
sinusis has approved for wound healing. That is why the
present study, therefore, focuses on delineation of the
antibacterial activities of extracts of H. micranthus and
its effects on wound by excision wound model. Many
plant materials including H. micranthus have been used
topically and systemically to enhance wound repair
though evidence is lacking. There is, however, a need to
study and provide evidence for the efficacy of H.
micranthus extract in the treatment of wounds. The
main compounds of the plant such as alkaloids, flavo-
noids, tannins, steroids, saponins, phenols, diterpines
and anthraquinones will support biological effects. The
results of pharmacological screening of H. micranthus
will have a contribution in the discovery of various me-




Ampicillin, ciprofloxacin, methanol (RFCL limited, New
Delhi, India), nutrient broth (India), blood agar, MacCon-
key agar, Mueller Hinton Agar, biochemical testing,
DMSO (dimethyl sulphoxide- Loba Chemie Pvt.Ltd.
Mumbai, India), phytochemical screening reagents, keta-
mine (ROTEXMEDICA, Germany), simple ointment base
and nitrofurazone ointment USP 0.2% (Galentic pharma,
India Pvt. Ltd.) were purchased and collected from the
respective sources.
Plant material collection and identification
Enough amounts of the fresh leaves of H. micranthus
were collected from Gondar area, Ethiopia during the
Month of January 2015. The plant was identified by a
Taxonomist (Mr. Melaku Wondaferash) and a voucher
specimen representing H. micranthus (specimen No. AA
004) was deposited at the National Herbarium, Department
of Biology, Addis Ababa University, Ethiopia.
Test organisms
In the present study, the gram positive bacterial strains
used were S. aureus (ATCC2923), S. pneumoniae
(ATCC137348) and S. pyogenes (ATCC19615) while gram
negative bacteria strains used were E. coli (ATCC1925525),
P.aeruginosa (ATCC27853), K.pneumoniae (ATCC70060)
and P. mirabilis (ATCC12386) obtained from the American
Type Culture Collection (ATCC) to determine the antibac-
terial activity of H. micranthus. The bacterial strains were
obtained from University of Gondar Referral Teaching
Hospital Laboratory and Microbiology Department. Pure
culture of bacteria was maintained at 4 °C on nutrient agar
slants. The identity of these bacterial isolates was confirmed
through the conventional biochemical tests [19, 21].
Experimental animals
Healthy adult Wistar albino rats of either sex were se-
lected randomly for the study. Rats were obtained from
animal breeding house of School of Pharmacy, Univer-
sity of Gondar. Rats of 12 weeks, weighing 160–220 g
were used for experiment. Each rat was housed in
2200cm2 polypropylene cage floor area under controlled
conditions at 19-25 °C and kept under 12/12 light/dark
cycle with free access to standard pellet feed brought
from Ethiopian Health and Nutrition Research Institute,
Addis Ababa and water ad libitum. They were all accli-
matized to the Pharmacology Laboratory prior to use.
The study was carried out according to the National
Research Council Guide for the Care and Use of
Laboratory Animals and Organization of Economic Co-
operation and Development (OECD) guide line [22, 23]
after obtaining the approval of the Institutional Animal
Ethical Committee (IAEC). Six animals in each group
and duration of observation required to obtain consist-
ent data were employed.
Experimental design
The study utilized an in vitro antibacterial and in vivo
experimental study for acute oral and dermal toxicity
test and for wound healing activity test. Crude extract of
the plant leaves was prepared with maceration. The
extract was then screened for phytochemical, acute oral
and dermal toxicity tests, antibacterial and wound heal-
ing activity tests by their respective methods.
Extraction procedure
Fresh matured leaves of H. micranthus was collected,
washed, dried under shade and extracted as described by
Kumar et al., [11] with slight modification. The dried
leaves were coarsely powdered using a mortar. Then,
this coarsely powdered plant was macerated in 80%
methanol to obtain the hydro-alcoholic crude extract
using Erlenmeyer flask for 3 days at room temperature.
After 72 h, the filtrate was separated from the marc by
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using filter paper (Whatman No.1). The marc was re-
macerated twice. Then the alcohol was allowed to evap-
orate from the filtrate with mild heating on dry oven
to dry at 40 °C and then the concentrated extract
was stored at 4 °C until the actual experiment is
done.
Preliminary phytochemical screening
The crude methanol extract was assessed for second-
ary metabolites such as phenol, tannin, flavonoids, sa-
ponins, terpenoids, triterpenes, diterpines, glycosides,
anthraquinones, alkaloids and steroids using standard
methods [6, 11, 20].
Acute oral toxicity test
Acute toxicity study was carried out using the limit test
dose of 2 g/kg as described by OECD (2008) guideline
−425 and Interagency Research Animal Committee Rec-
ommendation [22, 23]. Five animals of either sex were
fasted overnight but water was allowed and was adminis-
tered with the limit dose 2 g/kg of H. micranthus ex-
tract. Animals were observed individually for behavioral
profile (alertness, restlessness, irritability and fearful-
ness), autonomic profiles (defecation and urination),
neurologic profile (spontaneous activity, reactivity, touch
response, pain response and gait), physical states as
lacrimation, loss of appetite, tremors, hair erection, sali-
vation, diarrhea and for mortality after dosing at atten-
tively during the first 30 min, with special attention
given during the first 4 h, periodically during the first
24 h and daily thereafter for a total of 14 days.
Acute dermal toxicity test
The skin irritation test with 80% methanol extract of Hi-
biscus micranthus was conducted on rats. Animals
showing normal skin texture were housed in a cage. Five
rats were employed for this test and their skin was
shaved on the dorsal side, each about 400 mm2 areas
24 h before application of the sample. A limit test dose
of 2000 mg/kg of formulation was applied uniformly
over the shaved area for 24 h. The plant extract was held
in contact with the skin using a zinc oxide adhesive plas-
ter and a non-occlusive bandage dressing for 24 h. At
the end of the exposure period, the bandage and the test
materials were removed and observed for an adverse
skin reaction/irritation. Then, they were further ob-
served for 14 days for any signs of toxicity [24–27].
Methodology for detection of antibacterial activity
Inoculums preparation
The bacterial isolates were first grown in a nutrient
broth for 18 h before use. The microbial inoculums were
standardized by 0.5 McFarland. Inoculums preparation
of 0.5 McFarland turbidity standards was done by using
a sterile inoculating loop touch isolated colonies of the
same morphology were suspended in 5 ml of nutrient
broth in to sterile test tubes for the identified bacteria.
0.5 McFarland standards were vigorously agitated to tur-
bidity on a vortex mixer before use. As with the barium
sulfate standards, a 0.5 McFarland standard was compar-
able to a bacterial suspension of 108 cells per/ml. The
standard was compared visually to a suspension of bac-
teria in nutrient broth accordingly [21].
Antibacterial assay
The antibacterial activity of methanolic extracts of H.
micranthus leaves was tested against clinical isolates by
agar-well diffusion method as described by Sohelet al.,
and Bahur et al., [19, 27]. A Cork borer of 6 mm diam-
eter was used to punch well in agar plates to cut
uniform wells [19]. Then, an aliquot of 100 μl inocula
for each bacterial isolate was evenly spread by a sterile
glass spreader onto a previously bored on to Muller
Hinton Agar using sterilized cotton swab and was
allowed at room temperature. Different concentrations
of the extract (200, 400 and 800 μg/ml) were prepared
using DMSO as solvent. Subsequently, 200, 400 and
800 μg/ml extracts of leaves were poured into the wells.
Ciprofloxacin 5 μg and ampicillin 10 μg discs were used
as positive control. DMSO was used as a negative con-
trol. Then the plates were kept at 2-8 °C in a refrigerator
to allow diffusion of the extracts in to the agar and
further incubated at 37 °C for 24 h. The diameter of
zone of inhibition was measured to the nearest milli-
meter [19, 28]. The formation of clear inhibition zone of
≥7 mm diameters around the wells was regarded as sig-
nificant susceptibility of the organisms to the extract
[29]. The effect was compared to those of antibiotic
discs. The tests were performed in duplicates and the
mean was taken. The whole experiments were
performed under strict aseptic conditions.
Determination of Minimum inhibitory concentration (MIC)
and Minimum bactericidal concentration (MBC)
The MIC test was performed for bacteria species suscep-
tible by disc diffusion test and the estimation of MICs of
the extraction was investigated per the Clinical Labora-
tory Standards Institute [30]. MIC was conducted using
macro-tube serial dilution methods. The extract (stock)
solution was prepared and serially dilutions were done
in DMSO. The extract solutions were prepared in differ-
ent test tubes. The extract solution (5 mg/ml) was
serially diluted as 1:1, 1:2, 1:4, 1:8 and 1:16 to bring
5 mg/ml, 2.5 mg/ml, 1.25 mg/ml, 0.625 mg/ml and
0.3125 mg/ml concentrations respectively. Varying
concentration of the extract (5 mg/ml, 2.5 mg/ml,
1.25 mg/ml, 0.625 mg/ml and 0.3125 mg/ml) in test
tubes containing 10 ml nutrient broth was added and
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then a loopful of the test organisms was introduced in
each test tube. All inoculated dilutions were incubated
at 37Oc for 24 h. The lowest concentration of the plant
extract that retains its inhibitory effect resulting in no
growth (absence of turbidity) of a microorganism was
recorded as the MIC value of the extract.
Determination of MBC of the extract was also
investigated by the method described by the Clinical
Laboratory Standards Institute [30]. A loopful sample
was then taken from each set of test tubes with no vis-
ible growth in MIC assay and sub-cultured on freshly
prepared Nutrient agar plate and later incubated at 37OC
for 24 h. After incubation, the lowest concentration of
the plant extracts showing no bacteria growth was re-
corded as MBC.
Grouping and dosing of animals
The animals were randomly assigned to four groups of
each consisting of six rats each. The animals of Group I
was used for simple ointment base, Group II was served
as reference standard and treated with 0.2% w/w nitro-
furazone ointment and animals of Group III and IV were
treated with ointments prepared from 5% and 10% con-
centrations of methanolic extract of H. micranthus
respectively. Dose of ketamine anaesthesia (50 mg/kg,
ip) for wounding procedure was selected based on previ-
ous studies120mg/kg, ip [31], 30 mg/kg,ip [32] and
50 mg/kg sc [25]. The test doses were prepared freshly
on the day of the experiment.
Methods for wound healing activity
Ointment formulation
Two types of ointment formulations were prepared from
the extract. Five percent (w/w) and 10% (w/w), where 5 or
10 g of the extract were incorporated in to 100 g of simple
ointment base respectively [33, 34]. Nitrofurazone oint-
ment (0.2% w/w) was used as a standard drug for compar-
ing the wound healing potential of the extract [31, 34].
Methods for creating excision wound
The animals were anesthetized with ketamine 50 mg/kg
body weight. The rats were inflicted with excision
wounds as described by Mekonnen et al., and Morton
and Malone [25, 35]. The dorsal fur of the animals was
shaved with small scissors and the anticipated area of
the wound to be created was outlined on the back of the
animal with marker. The excision wound was made by
cutting away a circular area 210–240 mm2 and 1–2 mm
depth full thickness of skin from the depilated area along
the marking using toothed forceps, a surgical blade and
pointed scissors. The wound was left undressed to open
environment [25, 31].
Treatment methods
The ointment was topically applied once a day starting
from the day of the operation till complete epitheliza-
tion. This model was used to monitor wound contrac-
tion and wound closure time. Wound contraction was
calculated as percentage reduction in wound area. The
progressive changes in wound area were monitored
planimetrically by measuring the diameter every alter-
nate day. The period of epithelialization was calculated
as the number of days required for falling of the dead
tissue remnants of the wound without any residual raw
wound [31].
The wound area was measured on alternate days and
the epithelialization period recorded at the end of the
study. Wound contraction (%) was calculated using the
relation [36, 37]:
Wound contraction %ð Þ ¼ WA0−WAtð Þ=WA0½  100
Where:
WA0 ¼ the wound area on day zero
WAt ¼ the wound area on day t:
Data analysis
Statistical analysis was performed using one-way analysis
of variance (ANOVA) with post hoc Tukey’s multiple
range tests with SPSS version-16 for windows. P < 0.05
was considered significant and all data was expressed as
mean ± SEM.
Ethical considerations
Animal handling was done according to the guide lines
for Care and Use of Laboratory Animals [22] and
OECD-guidelines-425 [23]. The proposal was submitted
to Department of Pharmacology for approval and then
the study was undertaken after obtaining the approval of
IAEC of University of Gondar (IAEC approval letter No.
SoP4/407/2015 dated 28th April 2015). The certificate
of clearance was obtained from Department of
Pharmacology to proceed the research.
Results
Yield of the plant’s extract
The Hibiscus micranthus leaves were extracted for the
crude active extracts of 80% methanol. From 100 g of H.
micranthus leaves extract, 11.6%w/w was extracted using
methanol. The extract was greenish black.
Phytochemical screenenig
Chemical analysis of the powdered plant was carried out
qualitatively to associate the antibacterial and wound
healing activities of the plant extract. Preliminary
phytochemical screening of the leaves extract of H.
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micranthus revealed the presence of alkaloids, flavo-
noids, saponins, tannins, steroids, phenols, diterpines,
anthraquinones and the absence of terpenoids, glyco-
sides and triterpines (Table 1).
Antibacterial activity of plant extracts using agar well
diffusion
The extract showed antibacterial activity as indicated by
the zone of growth inhibition ranged from 14 ± .000–
22.67 ± 1.202 mm. S. aureus (which show significant dif-
ference with the positive control ampicillin at p = 0.021
and S. pneumoniae strain in a concentration dependent
fashion (which shows significant difference with the
positive control ampicillin at p = 0.003 and ciprofloxacin
at p = 0.016) had the largest zone of inhibition
(22.67 ± 1.202 mm) at concentration of 800 μg/ml and
400 μg/ml respectively followed by P.aeuruginosa[(which
shows significant difference with the positive control
ampicillin at p = 0.037 and ciprofloxacin at p < 0.001)
(18.33 ± .333 mm)] and K.pneumoniae[(which shows
significant difference with the positive control ampicillin
at p = 0.040 (16.33 ± 1.202 mm)] at a concentration of
400 μg/ml and 800 μg/ml respectively while S.pyogenes
had the smallest zone of inhibition (14 ± .000 mm) at a
concentration of 400 μg/ml. However, E.coli and P.mir-
abilis were found to be resistant (.00 ± .000 mm) to the
leaves extract at any of the applied doses (Table 2).
Minimum inhibitory concentration (MIC) and Minimum
bactericidal concentration (MBC)
MIC and MBC were tested for the methanol extract of H.
micranthus leaves and the results are presented in Table 4.
S. pneumoniae had the lowest MIC value (0.625 mg/ml),
while S. aureus and P.aeuruginosa had MIC value of
2.5 mg/ml and 1.25 mg/ml respectively. K.pneumoniae
had the highest MIC value of 5 mg/ml. Higher MBC of
5 mg/ml was observed against S. aureus, P. aeuruginosa
and K.pneumoniae. MBC value of 1.25 mg/ml against S.
pneumoniae was reported (Table 3).
Results of acute oral toxicity
All the rats which received H. micranthus at the dose up
to 2 g/kg body weight did not result in signs of toxicity
or mortality. The animals were physically active, con-
suming food and water as regular. Any sign of abnormal
behavior has not been noticed. Based on the result of
acute toxicity, LD50% was estimated to be above 2 g/kg
body weight.
Results of acute dermal toxicity
The purpose of this study was to assess the skin irrita-
tion potential of Hibiscus micranthus from a single
topical application. During the entire period of experi-
mentation, no animal showed a sign of skin and fur
change, edema, salivation, diarrhoea and any other
behavioral pattern.
Wound healing effect of Hibiscus micranthus in excision
wound model
The measurements of the progress of the wound healing
include by the NFZ ointment (0.2%w/w), extract oint-
ment 5 and 10% w/w and the control group (simple
ointment base) in the excision wound model are shown
in Table 4. The 5% and 10% w/w contained 5 g and 10 g
of the extract in 100 g of simple ointment base, respect-
ively. The two doses of the plant extract 5 and 10% w/w
exhibited significant wound contraction rate as com-
pared to NFZ ointment and simple ointment base
treated group from 6th to 16th day respectively
(p < 0.05). It was found that the wound healing contract-
ing ability of the extract ointment in different concentra-
tions was significantly greater (p < 0.05) than that of the
control (i.e. simple ointment treated group) as well as
reference standard (NFZ ointment) starting from the
sixth day onwards. The extract ointment produced
complete healing at the 16th day when 5 and 10% w/w
extract ointments were used. The extract treated wounds
were found to epithelialize faster compared to the con-
trol group.
Discussion
Now a day, medicinal plants play a major role in the
treatment of infectious disease [19, 38–42]. The World
Health Organization (WHO) estimates that plant extract
or their active constituents are used as folk medicine in
traditional therapies of 80% of the words population.
Ethnobotanical investigations have been found to recom-
mend main clues in the discovery and development of
traditionally used medicinal plants into modern drugs
[43]. The medicinal values of these plants lie in bioactive
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phytochemical constituents that produce definite physio-
logical function on the human body and those com-
pounds formed are the foundations of modern
prescription drugs as we know today [6].
Antibiotic resistance is a major concern and develop-
ment of new agents from plants could be useful in meet-
ing the demand for new antimicrobial agents with
improved safety and efficacy.
Newer antimicrobial agents from plant extracts may
be useful in food, dairy and pharmaceutical industries to
prevent contamination by limiting the microbial growth
[44]. The leaves extract of H. micranthus demonstrated
significant antibacterial activity against most of the test
organisms. The extract was more potent against gram-
positive S. aureus and S. pneumoniae with maximum
zone of growth inhibition of 22.67 ± 1.202 mm at
800 μg/ml and 400 μg/ml respectively. Though, S. pyo-
genes had the smallest zone of inhibition (14 ± .000 mm)
compared with other gram positive bacteria at a concen-
tration of 400 μg/ml, it was found that the extract had
an inhibitory effect on this strain.
The plant extract inhibited gram-positive microorgan-
isms better than the gram-negative ones. This is in
agreement with previous reports [45]. Although gram-
negative bacteria tend to have higher intrinsic resistance
to most antimicrobial agents [46], impressive activity
against some gram negative bacteria was observed. Low
values of MIC (0.625 mg/ml) and MBC (1.25 mg/ml)
demonstrated by the extract especially on S. pneumoniae
is an indication that the phytoconstituents have
Table 2 Diameter of zone of inhibition (mm) against bacteria by H.micranthus leaves extract
Bacterial strain Conc.μg/ml p-value Between Mean zone of inhibition(mm) ± SEM
Extract Cipr 5 μg Ampi 10 μg DMSO100μl
S. aureus 200 0.021 Extract-amp 18.33 ± 1.667 21.67 ± 1.202 25.33 ± 1.667 .00 ± .000
400 - - 20.00 ± 1.555
800 - - 22.67 ± 1.202
S.pneumoniae 200 - - 20.67 ± 1.764 19.33 ± .333 21.00 ± .577 .00 ± .000
400 - - 22.67 ± 1.202
800 0.016 0.03 Extract-cipr
Extract-amp
13.00 ± 1.528
S.pyogenes 200 - - .00 ± .000 23.33 ± .667 27.00 ± .577 .00 ± .000
400 - - 14 ± .000
800 - - .00 ± .000
P.aeuruginosa 200 <0.001 Extract-cipr .00 ± .000 27.00 ± .577 6.00 ± 6.00 .00 ± .000
400 0.037 Extract-amp 18.33 ± .333
800 <0.001 Extract-cipr .00 ± .000
K.pneumoniae 200 0.013 Extract-amp 13.67 ± 1.856 18.00 ± 1.453 20.00 ± .577 .00 ± .000
400 0.040 Extract-amp 14.67 ± .667
800 - - 16.33 ± 1.202
E.coli 200 - - .00 ± .000 23.67 ± 1.453 19.33 ± .333 .00 ± .000
400 - - .00 ± .000
800 - - .00 ± .000
P.mirabilis 200 - - .00 ± .000 30.00 ± .000 26.33 ± .333 .00 ± .000
400 - - .00 ± .000
800 - - .00 ± .000
Conc- concentration of the extract; Cipr-ciprofloxacin; Amp -ampicillin; DMSO–Dimethyl sulphoxide, mm-millimeter, μg-microgram, μl-microlitre; ml-mililitre;
SEM-standard error of the mean; ‘0’ - no zone of inhibition;(−) - no significant difference between extract and standard drugs. P-values <0.05 indicates significant
difference between the extract and the standard drugs or positive controls. Values greater than 6 mm diameter of the well indicate some activity
Table 3 MIC and MBC of H.micranthus leaves extract against
test organisms
Bacterial strain MIC (mg/ml) MBC (mg/ml)
S. aureus 2.5 5






ND Not Determined, MIC Minimum Inhibitory Concentration, MBC Minimum
Bactericidal Concentration, mg/ml milligram per milliliter
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bactericidal potential. Similarly, the MIC (1.25 mg/ml)
and MBC (5 mg/ml) exhibited against P. aeuruginosa.
The inhibitory effects of the extract of H. micranthus
leaves against pathogenic bacterial strains can introduce
the plant as potential candidate for drug development
for treatment of ailments caused by these pathogens.
The results of the antibacterial effect of H. micranthus
on E.coli and P. mirabilis indicate that these bacteria
present resistance even in higher concentration the fact
that the diameter of the inhibition zone was zero in all
petridishes inoculated by these strains. While the anti-
bacterial activities of the methanol extract of H.
micranthus leaves compared to standard antibiotics (cip-
rofloxacin and ampicillin) showed broad spectrum as its
activity were independent on gram reaction. The extract
tested showed antimicrobial activity against both gram
positive (S.aureus, S.pneumoniae and S.pyogenes) and
gram negative organisms (P.aeruginosa and K.pneumo-
niae). The Present investigation confirms, therefore, the
antibacterial activity of extracts of H. micranthus leaves.
These activities are supported by the presence of high
level of alkaloids, diterpines, tannins, saponins, phenols,
flavonoids and steroids which might be responsible for
the antibacterial activities [6, 46]. Anthraquinone also
has antibacterial effect as described by Marjorie Murphy
Cowan [47].
In the phytochemical screening of this study, the
methanol extract of H. micranthus showed positive indi-
cation for the presence of alkaloids, flavonoids, saponins,
tannins, steroids, phenols, diterpines and anthraqui-
nones. Therefore, the observed antibacterial activity of
the methanol extract can be attributed primarily by the
nature of biologically active components of the plant like
alkaloids, diterpines, tannins, saponins, phenols, flavo-
noids and steroids which are well known for their anti-
microbial activity [6, 44] supporting the traditional use
of the plant and secondarily by the stronger extraction
capacity of methanol could have produced a large
number of active constituents responsible for antibacter-
ial activity [8, 42]. Expected mode of antimicrobial ac-
tion of some secondary metabolites may be related for
example tannins inactivate microbial adhesins, enzymes
and cell envelope transport proteins; flavonoids targeted
on microbial membrane; alkaloids intercalate in to cell
wall and /or Deoxyribonucleic acid (DNA) where as
diterpines and phenolic substances disrupt microbial
membrane [47]. These secondary compounds may come
into play either individually or synergistically to confer
the antibacterial potential of this plant.
From the literature, the n-hexane extract of the H.
micranthus leaves contains aldehydes that has been used
for antiseptic and also contains phenolics like eugenol
usually posses antioxidant, antimicrobial, antifungal and
used as several other therapeutic uses [10]. The highest
anthocyanin content of methanol extract of H. micranthus
may be responsible for antioxidant effects [8].
These were in support of the current study in having
antibacterial and wound healing effect. Findings of the
present study clearly demonstrate the scientific basis of
traditional medication with the extracts prepared from
H. micranthus and reveals its potential use as comple-
mentary and alternative medicine.
Wound healing process begins with restoration of
damaged tissue as closely as possible to its natural state
and wound contraction is the course of shrinkage in
wounded area [48]. In the present study, topical applica-
tion of H. micranthus leaves extract on excision wound
showed increased rate of wound contraction and re-
duced epithelialization period in rats. Thus, the effect of
the extract on wound contraction and epithelialization
suggests, it may enhance epithelial cells migration and
proliferation as well as the formation, migration and ac-
tion of myofibroblasts. The extract may also stimulate
processes associated with tissue regeneration. The
significant responses to the extract reported above may
be attributed to properties that include antioxidant,
Table 4 Effect of the methanol extract of H.micranthus leaves on excision wound model (n = 6)
Post wounding days Wound surface area (mean ± SEM) in mm2 and percentage of wound contraction
Ointment base Nitrofurazone ointment (0.2%w/w) Extract ointment (5% w/w each) Extract ointment (10% w/w each)
0 220.60 ± 2.713 (0.0) 213.80 ± 7.971 (0.0) 227.80 ± 5.643 (0.0) 230.80 ± 2.871 (0.0)
2 180.80 ± 4.769 (18.04) 161.20 ± 7.010 (24.60) 166.00 ± 9.508 (27.13) 167.80 ± 12.395 (27.30)
4 145.40 ± 7.096 (34.09) 136.00 ± 6.782 (36.39) 119.20 ± 10.851 (47.67) 117.40 ± 9.765 (49.13)
6 113.80 ± 5.643 (48.41) 80.00 ± 8.390 (62.58) 76.20 ± 8.777* (66.55) 83.40 ± 10.028 (63.86)
8 70.80 ± 11.128 (67.91) 44.40 ± 4.261 (79.23) 36.60 ± 5.600* (83.93) 53.60 ± 7.467 (76.78)
10 34.60 ± 4.707 (84.32) 20.60 ± 2.088 (90.36) 16.80 ± 1.497* (92.63) 29.40 ± 5.400 (87.26)
12 19.80 ± 1.428 (91.02) 14.40 ± 2.400 (93.26) 10.80 ± 1.200* (95.26) 11.60 ± 2.400* (94.97)
14 9.40 ± 1.166 (95.74) 7.20 ± 3.200 (96.63) 2.40 ± 0.400 (98.95) 5.20 ± 1.068 (97.75)
16 6.60 ± 0.872 (97.00) 3.80 ± 2.835 (98.22) 1.60 ± 1.666 (99.30) 2.00 ± 1.095 (99.13)
Values in parenthesis indicate percentage of wound contraction.* significant differences at p < 0.05 (statistical analysis was done by one-way analysis of variance
(ANOVA) followed by Tukey’s test for multiple comparisons)
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anticonvulsant, and hypoglycemic activities [31]. A var-
iety of in vitro and in vivo experiments have shown that
some plants metabolites such as tannins, phenolic com-
pounds, flavonoids and terpenoids promote wound heal-
ing process mainly due to their astringent and
antimicrobial property which seems to be responsible
for wound contraction and increased rate of epitheliali-
zation [49]. Flavonoids, tannins and simple phenolic
compounds possess anti-inflammatory and antioxidant
properties and could contribute to the wound healing
properties of H. micranthus. Flavonoids are known to re-
duce lipid per oxidation by preventing or slowing onset
of cell necrosis and improving vascularity, hence increas-
ing the strength of collagen fibers by increasing circula-
tion or by preventing cell damage and by promoting
DNA synthesis [49]. Previous studies also showed that
the chemical constituents of H. micranthus contained
the anthocyanin which may be responsible for antioxi-
dant effects [8]. The extract showed positive indication
for the presence of alkaloids, flavonoids, saponins, tan-
nins, phenols, diterpines and anthraquinones which are
responsible and supported the wound healing activity.
These bioactive agents usually modulate one or more
phases of the healing process and are multifunctional
natural products that act through multiple targets by be-
ing anti-inflammatory, antioxidant, etc.
Alkaloids promote early phases of wound healing (≤
7 days), stimulate the growth of colonies from fibroblast
precursors. On the other hand, saponins have been
shown to modulate wound cells function which can in-
crease both fibroblast proliferation and migration, show-
ing greater cell density, more regularly organized dermis
and more newly formed blood vessels.
The anthraquinone has been shown to promote exci-
sional wound repair in rats via complex mechanism in-
volving stimulation of tissue regeneration. Tannins
typically act as astringents which are responsible for
wound contraction and increased rate of epithelialization
at the granulation formation and scar remolding phases.
The wound healing effect of tannins may also be attrib-
uted to their anti-inflammatory activity due to their anti-
oxidant action [50]. Phenolic compounds have been
documented to possess potent antioxidant and free rad-
ical scavenging effect, which is believed to be one of the
most important components of wound healing. Sulfur
containing compounds are also important in healing ac-
celerated efficacy and antimicrobial potency [34]. The
extract has been reported to have a broad spectrum anti-
bacterial activity in this study, which also seemed to have
beneficial effects on promoting wound healing.
The result showed that the wound area recorded for
each extract-ointment decreased as the days of exposure
increased, while the respective percentage wound con-
traction increased with increase in the number of days
of exposure to the extract ointments. It was observed that
the wound healing contracting ability of the extract oint-
ment in different concentrations was significantly greater
(p < 0.05) than that of the control (i.e. simple ointment
treated group) as well as reference standard (NFZ oint-
ment). The 5% (w/w) extract ointment treated groups
showed significant wound healing (p < 0.05) from the 6th
day onwards where as the 10% (w/w) extract ointment
treated group showed significant wound healing (p < 0.05)
from the 12th day. The percentage of wound contraction
was somewhat much more with the 5% w/w extract oint-
ment treated group (1.60 ± 1.666 mm2) than the 10% w/w
extract ointment treated group (2.00 ± 1.095 mm2) and the
NFZ ointment (3.80 ± 2.833 mm2) area on the 16th day
respectively. The wound healing activity of the plant
extract may also be due to its angiogenic and mitogenic
potential leading to increased cellular proliferation and
increased collagen synthesis. Because of these properties,
H. micranthus has been used widely in herbal medicines
for burns, psoriasis and prevention of scar formation
following surgery [6].
It appears that H. micranthus has prohealing effect as
evidenced by the above findings and was able to promote
epithelialization either by facilitating the proliferation of
epithelial cells or by increasing the viability of epithelial
cells. Due to the various properties as discussed above,
H. micranthus could be used to treat open wounds;
however, confirmation of this conclusion requires
clinical evaluation.
Conclusion
The present study suggests that methanolic leaf extract of
H. micranthus has a potential antibacterial activity against
the tested microoragnisms and promoted a rapid would
healing activity. These effects would be attributed to the
presence of phytoconstituents like alkaloids, flavonoids,
saponins, tannins, steroids, phenols, anthraquinones and
diterpines. The extract was safe and shows no sign of tox-
icity or mortality with a dose of 2 g/kg body weight.
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